I think the reality is that management is well aware of all the stuff that is written on this board.  I'm sure there is at least one person on the management team or the board that is plugged into this forum to gauge 'retail investor' sentiment.  My guess is Paul Moon at a minimum.........I believe he's still on the payroll. :)  Anyway, if what I suspect is true then they aren't listening and likely have a solid counter argument to most of the negative comments that are made here.  I'm sure they want to make money on this thing too.

Don M is surely aware of who his critics are.  Nevertheless for now he's the man and that's just the way it is.  Things can change in a heartbeat so you never know what can happen.  So, for those that can continue to stomach this, stay tuned.

RVX and it's lead product is a new thing medical science wise and it's had a bumpy ride so far.  That probably explains a good portion of where the company, and the stock, is at.  If you try to promote the hell out, based on it's track record so far, merely to bump up the share price I think it will be a short-lived event that will only serve to further erode it's credibility.  It's a big risk in the absence of a trial result with statistical significance on defined primary endpoints.

Let's face it, true success now pretty much lies with a successful outcome of BoM2.  This stock had its glory day run up to $25 or whatever many years ago.  Now its 'where's the beef time'.  Covid hasn't helped get this trial on a faster track so the sooner we get this virus behind us the better because the clock is ticking.

JM'very'HO

P